Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) EBIT Margin (2016 - 2026)

Cryo Cell International's EBIT Margin history spans 17 years, with the latest figure at 9.96% for Q1 2026.

  • Quarterly results put EBIT Margin at 9.96% for Q1 2026, down 329.0% from a year ago — trailing twelve months through Feb 2026 was 0.61% (down 195.0% YoY), and the annual figure for FY2025 was 1.53%, down 31.0%.
  • EBIT Margin for Q1 2026 was 9.96% at Cryo Cell International, up from 50.58% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 24.29% in Q3 2025 to a low of 205.37% in Q4 2023.
  • The 5-year median for EBIT Margin is 13.25% (2025), against an average of 7.18%.
  • The sharpest move saw EBIT Margin crashed -16773bps in 2023, then soared 16781bps in 2024.
  • Year by year, EBIT Margin stood at 37.64% in 2022, then tumbled by -446bps to 205.37% in 2023, then skyrocketed by 82bps to 37.56% in 2024, then crashed by -35bps to 50.58% in 2025, then soared by 120bps to 9.96% in 2026.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 9.96%, 50.58%, and 24.29% for Q1 2026, Q4 2025, and Q3 2025 respectively.